NRG Therapeutics partners with Precision BioSearch to expand management team
![](https://precisionbiosearch.com/wp-content/uploads/2023/04/LinkedIn-NRG-therapeutics-copy-1024x536.jpg)
Precision BioSearch was pleased to partner with NRG Therapeutics, an innovative neuroscience company targeting mitochondrial dysfunction, to secure Gilles Ouvry as VP Chemistry and Vad Lazari as VP Biology.
Hiring with precision: how biotech investment headwinds impact leadership hiring
![How biotech investment headwinds impact leadership hiring](https://precisionbiosearch.com/wp-content/uploads/2023/04/LinkedIn-1200x628px-marketplace-final-1024x536.jpg)
After several record years for biotech investment, the market has taken a downward turn in the past year.
Precision BioSearch secures CEO for Oxford spin-out, Dark Blue Therapeutics
![precision bio search Dark Blue Therapeutics](https://precisionbiosearch.com/wp-content/uploads/2023/04/LinkedIn-1200x628px-DrMack-copy-1024x536.jpg)
Precision BioSearch partnered with Dark Blue Therapeutics, a biotech company developing a pipeline of oncology programs from the University of Oxford and therapeutics accelerator LAB282.
Pangea appoints Alleyn Plowright as VP, Drug Discovery & Preclinical Development
![](https://precisionbiosearch.com/wp-content/uploads/2023/01/LinkedIn_post2-1024x535.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
2022 – A Year in Review Highlights & successes in supporting the biotech sector
![](https://precisionbiosearch.com/wp-content/uploads/2023/01/LinkedIn_posts-768x401-1.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Our Co-founder, Jemma Challinor, presents at the OBN Awards 2022
![](https://precisionbiosearch.com/wp-content/uploads/2022/11/LinkedIn_posts-1024x535.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Malcolm Silander is speaking at ‘Building Success for your Organisation’.
![](https://precisionbiosearch.com/wp-content/uploads/2022/09/LinkedIn_posts2-1024x524.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Precision BioSearch is delighted to be sponsoring the OBN Awards 2022
![](https://precisionbiosearch.com/wp-content/uploads/2022/09/LinkedIn_posts-1-1024x524.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Precision BioSearch secures CSO for leading cell and gene therapy company, Ixaka
![](https://precisionbiosearch.com/wp-content/uploads/2022/07/Pic-PR2.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.
Tom Coulter joins Dalriada as Head, Drug Discovery Programs and Partnerships
![tom Coulter joins dalriada](https://precisionbiosearch.com/wp-content/uploads/2022/05/pbs-news-1-1024x530.jpg)
Precision BioSearch is delighted to congratulate Tom Coulter on his appointment as Head, Drug Discovery Programs and Partnerships with Dalriada Drug Discovery.